Last Updated on December 16, 2024 by The Health Master
Genetic Disorder
Neurocrine Biosciences has made significant strides in the treatment of Congenital Adrenal Hyperplasia (CAH) with the recent U S Food and Drugs Administration (USFDA) approval of Crenessity. This groundbreaking drug offers a new approach to managing this rare genetic disorder.
Understanding Congenital Adrenal Hyperplasia (CAH)
CAH is a complex condition that affects the adrenal glands, leading to hormonal imbalances.
Individuals with CAH often experience:
- Cortisol Deficiency: This can result in fatigue, weakness, and difficulty managing stress.
- Androgen Excess: In females, this can lead to masculinizing effects like excessive hair growth, irregular menstrual cycles, and infertility. In males, it may cause early puberty.
How Crenessity Works
Crenessity is designed to target the root cause of androgen excess in CAH.
By selectively reducing androgen production, it helps to:
- Normalize Hormone Levels: Crenessity works in conjunction with glucocorticoids to achieve optimal hormonal balance.
- Reduce Glucocorticoid Dosage: By addressing androgen excess, Crenessity allows for a lower dosage of glucocorticoids, minimizing potential side effects.
Clinical Trial Results
The efficacy of Crenessity was demonstrated in two clinical trials:
- Adult Trial: Patients treated with Crenessity experienced a significant reduction in glucocorticoid dosage compared to the placebo group, while maintaining control over androgen levels.
- Pediatric Trial: Crenessity effectively reduced glucocorticoid dosage in pediatric patients with CAH, further highlighting its potential to improve quality of life.
The Future of CAH Treatment
The USFDA approval of Crenessity marks a significant milestone in the treatment of CAH. This innovative therapy offers hope to patients and their families by providing a more effective and well-tolerated treatment option.
-
What is Congenital Adrenal Hyperplasia (CAH)?
CAH is a rare genetic disorder affecting the adrenal glands, leading to hormonal imbalances.
-
How does Crenessity work?
Crenessity reduces androgen production, thereby minimizing the need for high doses of glucocorticoids.
-
When will Crenessity be available?
Crenessity is expected to be commercially available within a week of USFDA approval.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
Disclaimer: This content, provides generic information only. It is in no way a substitute for a qualified medical opinion. Always consult a specialist or your own doctor for more information. The Health Master does not claim responsibility for this information.
Double Approval: New Pneumonia Drugs Get CDSCO and USFDA Nod
USFDA approval granted for Latanoprost Ophthalmic Solution
USFDA approval granted for Sitagliptin and Metformin Hydrochloride Tablets
USFDA approval granted for Medical Device for heart condition
USFDA approval granted for Diltiazem Hydrochloride extended-release capsules
USFDA approval granted for Fludrocortisone Acetate Tablets
Aurobindo Pharma Faces Rs 11 Crore GST Demand
Forms: All types for Hospital RMI
Key Notes on Revised Schedule M: Point No. 7 – Product Recall
Double Approval: New Pneumonia Drugs Get CDSCO and USFDA Nod
Govt Expands Medical Device Testing Laboratories
Key Notes on Revised Schedule M: Point No. 6 – Complaints and Adverse reaction
NABL reforms Accreditation Processes to boost Testing Laboratories
Ayush Ministry Amends D&C Act: A Boon for Homoeopathy
Brazilian Regulators successfully completes GMP Audit of Alembic Pharma
CDSCO approval granted to market Insulin Inhalation Powder
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
